BGT
Director Trades
| Date | Director | Value |
|---|---|---|
| 21/7/25 | A. Guthrie | $5,000 |
| 21/7/25 | A. Ding | $500,000 |
| 21/7/25 | P. May | $5,000 |
| 21/7/25 | T. Grogan | $5,000 |
Company News
Bio-Gene Reports Strong Flavocide Results Against Ticks to Leading US Lyme Disease Conference
Bio-Gene Technology (ASX: BGT) has released new data confirming that its lead compound Flavocide delivers strong activity against ticks responsible for spreading Lyme disease in the United States. Presented by Purdue University researchers at the International Conference on Lyme Borreliosis and Other Tick-Borne Diseases in Chicago, the findings showed that Flavocide achieved more than 90% […]
Bio-Gene awarded $3m in US grants to develop insecticides for military use
Bio-Gene Technology (ASX: BGT) has been awarded $3 million in grants by the US Department of Defense to develop insecticide products to protect its workforce from threats posed by disease-carrying species including mosquitoes and ticks. The grants have been provided under the government’s Deployed Warfighter Protection research program. The program aims to identify and test […]
Bio-Gene signs public health control partnership with Clarke Mosquito Control
Just over three months since seeing its insecticide products pass US trials, agriculture technology development company Bio-Gene Technology (ASX: BGT) has unveiled a partnership with US-based Clarke Mosquito Control to develop its Flavocide and Qcide products for use in public health mosquito control in North, South and Central America. Clarke is currently the largest public […]
US trials confirm Bio-Gene’s Flavocide to be an effective control for mosquito-related diseases
The results of collective US trials by Australian ag-tech development company Bio-Gene Technology (ASX: BGT) have confirmed the natural compound product Flavocide can control the Anopheles gambiae mosquito species which carries malaria and is increasingly resistant to commonly-used sprays. Conducted at Purdue University’s world-leading entomology faculty which specialises in vector control, the trials showed that […]
Bio-Gene achieves key milestone during development of its Flavocide pesticide
Agriculture technology (AgTech) company Bio-Gene Technology (ASX: BGT) has reported results from a recent grain storage program and said its Flavocide product was able to meet key industry standards. Results confirmed that Flavocide continued to demonstrate control over offspring of adult Lesser grain borer – a type of insect that first originated in South America but […]
Bio-Gene Technology and BASF team-up to advance Flavocide pest control technology
Bio-Gene Technology (ASX: BGT) has secured a partnership with world leading chemical company BASF, with the duo planning to develop Bio-Gene’s Flavocide technology for use is stored grain pest control across Australia. The Queensland Government’s Department of Agriculture & Fisheries (DAF) will carry out the research with BASF to contribute both funding and expertise. Research […]
Bio-Gene and Qld Govt knock out grain pests with Flavocide combinations
Bio-Gene Technology (ASX: BGT) has achieved initial positive results using combinations of its Flavocide insecticide with grain protection compounds to fight key grain-storage pests, as part of a research venture with the Queensland Government’s Department of Agriculture and Fisheries (DAF). The department’s laboratory studies showed the full spectrum of pests were controlled effectively, including strains […]
Bio-Gene serves up next generation of novel, environmentally friendly insecticides
Newly-listed ag-tech company Bio-Gene Technology (ASX: BGT), focusing on the next generation of insecticides says that it is progressing toward development of a range of products based on a new discovery. The company says its patented beta-triketone-based insecticides could achieve better outcomes for end-users such as farmers, but without becoming susceptible to growing natural resistance […]
Initial toxicity results indicate Bio-Gene’s next generation insecticide is safe
AgTech developer Bio-Gene Technology (ASX: BGT) has received positive safety results from toxicology studies into its flavesone chemical, which is part of its next generation insecticides. Bio-Gene’s active ingredient flavesone is incorporated in the company’s Flavocide-branded products. Flavesone has been developed from naturally-occurring beta-triketone chemicals, in what Bio-Gene anticipates will address insecticide resistance and toxicity. […]
